REZOLUTE, INC. Shares Outstanding (Cover Page)
REZOLUTE, INC. (RZLT) had Shares Outstanding (Cover Page) of 96.72 million shares as of 2026-09-21, per its 10-K filed 2026-09-24.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-24
- 2026-09-21: Entity Common Stock, Shares Outstanding 96.72M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 96.29M shares.
- 2026-02-09: Entity Common Stock, Shares Outstanding 95.70M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 92.73M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-21 | 96.72M shares 10-K · filed 2026-09-24 |
| 2026-05-08 | 96.29M shares 10-Q · filed 2026-05-12 |
| 2026-02-09 | 95.70M shares 10-Q · filed 2026-02-12 |
| 2025-11-04 | 92.73M shares 10-Q · filed 2025-11-06 |
| 2025-09-15 | 90.81M shares 10-K · filed 2025-09-17 |
| 2025-05-09 | 85.52M shares 10-Q · filed 2025-05-13 |
| 2025-02-07 | 60.54M shares 10-Q · filed 2025-02-12 |
| 2024-11-05 | 57.94M shares 10-Q · filed 2024-11-07 |
| 2024-09-13 | 55.37M shares 10-K · filed 2024-09-19 |
| 2024-05-13 | 40.14M shares 10-Q · filed 2024-05-15 |
| 2024-02-09 | 39.63M shares 10-Q · filed 2024-02-13 |
| 2023-11-10 | 39.63M shares 10-Q · filed 2023-11-13 |
| 2023-09-08 | 36.83M shares 10-K · filed 2023-09-14 |
| 2023-05-08 | 36.83M shares 10-Q · filed 2023-05-11 |
| 2023-02-06 | 36.83M shares 10-Q · filed 2023-02-10 |
| 2022-11-07 | 36.83M shares 10-Q · filed 2022-11-09 |
| 2022-09-08 | 38.83M shares 10-K · filed 2022-09-15 |
| 2022-05-06 | 33.58M shares 10-Q · filed 2022-05-12 |
| 2022-02-07 | 15.56M shares 10-Q · filed 2022-02-09 |
| 2021-11-10 | 15.44M shares 10-Q · filed 2021-11-12 |
| 2021-09-08 | 8.62M shares 10-K · filed 2021-09-15 |
| 2021-05-12 | 8.35M shares 10-Q · filed 2021-05-17 |
| 2021-02-08 | 8.35M shares 10-Q · filed 2021-02-10 |
| 2020-11-09 | 8.35M shares 10-Q · filed 2020-11-12 |
| 2020-10-09 | 8.35M shares 10-K · filed 2020-10-13 |
| 2020-05-08 | 293.32M shares 10-Q · filed 2020-05-14 |
| 2020-02-07 | 293.32M shares 10-Q · filed 2020-02-12 |
| 2019-11-11 | 293.32M shares 10-Q · filed 2019-11-14 |
| 2019-09-05 | 293.32M shares 10-K · filed 2019-09-10 |
| 2019-05-07 | 210.39M shares 10-Q · filed 2019-05-10 |
| 2019-02-11 | 61.87M shares 10-Q · filed 2019-02-14 |
| 2018-12-14 | 62.17M shares 10-Q · filed 2018-12-14 |
| 2018-10-15 | 62.17M shares 10-K · filed 2018-10-15 |
| 2018-05-15 | 62.17M shares 10-Q · filed 2018-05-15 |
| 2018-02-14 | 54.07M shares 10-Q · filed 2018-02-14 |
| 2017-11-14 | 53.73M shares 10-Q · filed 2017-11-14 |
| 2017-09-21 | 53.73M shares 10-K · filed 2017-09-22 |
| 2017-05-15 | 47.68M shares 10-Q · filed 2017-05-15 |
| 2017-02-02 | 40.95M shares 10-Q · filed 2017-02-02 |
| 2016-11-14 | 40.95M shares 10-Q · filed 2016-11-14 |
| 2016-09-26 | 35.53M shares 10-K · filed 2016-09-28 |
| 2016-05-16 | 24.34M shares 10-Q · filed 2016-05-16 |
| 2016-02-16 | 24.34M shares 10-Q · filed 2016-02-16 |
| 2015-11-13 | 24.34M shares 10-Q · filed 2015-11-16 |
| 2015-09-25 | 24.34M shares 10-K · filed 2015-09-28 |
| 2015-05-15 | 24.34M shares 10-Q · filed 2015-05-15 |
| 2015-02-17 | 22.00M shares 10-Q · filed 2015-02-17 |
| 2014-11-12 | 18.22M shares 10-Q · filed 2014-11-12 |
| 2014-09-25 | 18.09M shares 10-K · filed 2014-09-30 |
| 2014-05-13 | 17.72M shares 10-Q · filed 2014-05-14 |
| 2014-02-12 | 40.00M shares 10-Q · filed 2014-02-13 |
| 2013-11-08 | 40.00M shares 10-Q · filed 2013-11-12 |
| 2013-09-05 | 40.00M shares 10-K · filed 2013-09-11 |
| 2013-05-10 | 40.00M shares 10-Q · filed 2013-05-15 |
| 2013-02-12 | 40.00M shares 10-Q · filed 2013-02-14 |
| 2012-11-14 | 4.10M shares 10-Q · filed 2012-11-19 |
| 2012-09-28 | 4.10M shares 10-K/A · filed 2012-11-09 |
| 2012-05-14 | 3.93M shares 10-Q · filed 2012-05-15 |
| 2012-02-08 | 3.84M shares 10-Q · filed 2012-02-14 |
| 2011-11-10 | 3.84M shares 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |